Dec 5, 2019 12:00 pm EST Enzo Biochem Schedules Teleconference to Discuss First Quarter 2020 Results Tuesday, December 10, 2019 At 4:30 PM E.T.
Oct 11, 2019 9:00 am EDT Enzo Biochem Schedules Teleconference to Discuss Fourth Quarter and Fiscal Year 2019 Results Tuesday, October 15, 2019 at 4:30 PM E.T.
Sep 24, 2019 9:00 am EDT New York State Health Department Approves Hepatitis B Virus Quantitative Clinical Assay
Aug 5, 2019 9:00 am EDT Enzo Biochem, Inc. Announces Issuance of United States Patent for Advanced Nucleic Acid Hybridization Probe Technology for Clinical and Research Applications
Jul 11, 2019 9:00 am EDT Enzo Biochem Announces Key Transformative Initiatives to Propel and Accelerate Growth In its Lab Business
Jun 5, 2019 9:00 am EDT Enzo Biochem Schedules Teleconference to Discuss Third Quarter 2019 Results Tuesday, June 11, 2019 at 8:30 AM E.T.
May 10, 2019 10:48 am EDT Enzo Biochem Inc. Announces Issuance of United States Patent for Treatment of Liver Cancer Using Ozanimod
Mar 11, 2019 4:10 pm EDT Enzo Biochem Reports Second Fiscal Quarter and First Half 2019 Results and Reports Progress on Its Investments and Strategic Goals
